Imaging- and therapeutic targets in neoplastic and musculoskeletal inflammatory diseas
[18F] Fluorodeoxyglucose (FDG) positron emission tomography (PET) is a useful imaging tool in the ma...
International audienceBACKGROUND: Peritoneal carcinomatosis (PC) is associated with a very poor prog...
PURPOSE: The diagnosis of peritoneal carcinomatosis secondary to ovarian cancer is a real challenge ...
Purpose To evaluate whether PET/CT could be used to assess the extent of colorectal peritoneal metas...
Purpose: To evaluate whether PET/CT could be used to assess the extent of colorectal peritoneal meta...
Background : Adequate staging is essential in patients with peritoneal carcinomatosis (PC) from colo...
AIM: Peritoneal carcinomatosis is a common evolution of neoplasms and the terminal stage of disease...
[18F]Fluorodeoxyglucose (FDG) positron emission tomography (PET) is a useful imaging tool in the evo...
Positron emission tomography (PET) using [(18)F]-fluoro-2'-deoxy-D-glucose (FDG) has an added value ...
Objective: Whole-body fluorodeoxyglucose-positron emission tomography (FDG-PET) has proved effective...
Peritoneal carcinomatosis can be difficult to diagnose, as CT is insensitive, with peritoneal biopsy...
Purpose: to evaluate the diagnostic accuracy of (18) F-FDG positron emission tomography/ computerize...
OBJECTIVES: To investigate the role of whole-body fluorine-18-2-deoxy-2-fluoro-d-glucose positron em...
Colorectal cancer is the third most commonly diagnosed cancer, accounting for 53,219 deaths in 2007 ...
Background: The peritoneum is the preferred site of metastasis from several primary malignancies, an...
[18F] Fluorodeoxyglucose (FDG) positron emission tomography (PET) is a useful imaging tool in the ma...
International audienceBACKGROUND: Peritoneal carcinomatosis (PC) is associated with a very poor prog...
PURPOSE: The diagnosis of peritoneal carcinomatosis secondary to ovarian cancer is a real challenge ...
Purpose To evaluate whether PET/CT could be used to assess the extent of colorectal peritoneal metas...
Purpose: To evaluate whether PET/CT could be used to assess the extent of colorectal peritoneal meta...
Background : Adequate staging is essential in patients with peritoneal carcinomatosis (PC) from colo...
AIM: Peritoneal carcinomatosis is a common evolution of neoplasms and the terminal stage of disease...
[18F]Fluorodeoxyglucose (FDG) positron emission tomography (PET) is a useful imaging tool in the evo...
Positron emission tomography (PET) using [(18)F]-fluoro-2'-deoxy-D-glucose (FDG) has an added value ...
Objective: Whole-body fluorodeoxyglucose-positron emission tomography (FDG-PET) has proved effective...
Peritoneal carcinomatosis can be difficult to diagnose, as CT is insensitive, with peritoneal biopsy...
Purpose: to evaluate the diagnostic accuracy of (18) F-FDG positron emission tomography/ computerize...
OBJECTIVES: To investigate the role of whole-body fluorine-18-2-deoxy-2-fluoro-d-glucose positron em...
Colorectal cancer is the third most commonly diagnosed cancer, accounting for 53,219 deaths in 2007 ...
Background: The peritoneum is the preferred site of metastasis from several primary malignancies, an...
[18F] Fluorodeoxyglucose (FDG) positron emission tomography (PET) is a useful imaging tool in the ma...
International audienceBACKGROUND: Peritoneal carcinomatosis (PC) is associated with a very poor prog...
PURPOSE: The diagnosis of peritoneal carcinomatosis secondary to ovarian cancer is a real challenge ...
DOI
Add to ORKG